This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2016 Jun;63(6):2018.

doi: 10.1002/hep.28489. Epub 2016 Mar 25.

Liver capsule: Molecular-based signatures in hepatocellular carcinoma

Amanda J Craig¹, Augusto Villanueva^{1

2}

Affiliations

Affiliations

¹ Division of Liver Diseases, Liver Cancer Program.
² Division of Hematology and Medical Oncology, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.

PMID: 26856972
DOI: 10.1002/hep.28489

Review

Liver capsule: Molecular-based signatures in hepatocellular carcinoma

Amanda J Craig et al. Hepatology. 2016 Jun.

. 2016 Jun;63(6):2018.

doi: 10.1002/hep.28489. Epub 2016 Mar 25.

Authors

Amanda J Craig¹, Augusto Villanueva^{1

2}

Affiliations

¹ Division of Liver Diseases, Liver Cancer Program.
² Division of Hematology and Medical Oncology, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.

PMID: 26856972
DOI: 10.1002/hep.28489

No abstract available

PubMed Disclaimer

Similar articles

Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH, Huang CC, Liu LF, Lin PR, Liu SY, Chang HW, Changchien CS, Lee CM, Chuang JH, Tai MH. Hu TH, et al. Cancer. 2003 Oct 1;98(7):1444-56. doi: 10.1002/cncr.11653. Cancer. 2003. PMID: 14508832
H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
Liu T, Chen J, Xiao S, Lei X. Liu T, et al. Tumour Biol. 2016 May;37(5):6419-28. doi: 10.1007/s13277-015-4490-z. Epub 2015 Dec 2. Tumour Biol. 2016. PMID: 26631039
Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X, Hu ZP, Li Z, Gao PJ, Zhu JY. Cui X, et al. World J Gastroenterol. 2015 Jul 28;21(28):8588-604. doi: 10.3748/wjg.v21.i28.8588. World J Gastroenterol. 2015. PMID: 26229401 Free PMC article.
Roles of circular RNAs in the progression of hepatocellular carcinoma and their values as diagnostic and prognostic biomarkers.
Zhu J, Li J, Wei Y, Wang J, Zhang XY. Zhu J, et al. Gene. 2021 Jan 30;767:145175. doi: 10.1016/j.gene.2020.145175. Epub 2020 Sep 28. Gene. 2021. PMID: 33002570 Review. No abstract available.
Staging of hepatocellular carcinoma.
Yan P, Yan LN. Yan P, et al. Hepatobiliary Pancreat Dis Int. 2003 Nov;2(4):491-5. Hepatobiliary Pancreat Dis Int. 2003. PMID: 14627506 Review.

See all similar articles

Cited by

5mC and H3K9me3 of TRAF3IP2 promoter region accelerates the progression of translocation renal cell carcinoma.
Yang L, Chen Y, Liu N, Lu Y, Li X, Ma W, Gan W, Li D. Yang L, et al. Biomark Res. 2022 Jul 27;10(1):54. doi: 10.1186/s40364-022-00402-3. Biomark Res. 2022. PMID: 35897085 Free PMC article.
Validating RRP12 Expression and Its Prognostic Significance in HCC Based on Data Mining and Bioinformatics Methods.
Wei C, Wang B, Chen ZH, Xiao H, Tang L, Guan JF, Yuan RF, Yu X, Hu ZG, Wu HJ, Dai Z, Wang K. Wei C, et al. Front Oncol. 2022 Feb 1;12:812009. doi: 10.3389/fonc.2022.812009. eCollection 2022. Front Oncol. 2022. PMID: 35178347 Free PMC article.
KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma.
Li WC, Xiong ZY, Huang PZ, Liao YJ, Li QX, Yao ZC, Liao YD, Xu SL, Zhou H, Wang QL, Huang H, Zhang P, Lin JZ, Liu B, Ren J, Hu KP. Li WC, et al. Aging (Albany NY). 2019 Oct 2;11(19):8169-8182. doi: 10.18632/aging.102311. Epub 2019 Oct 2. Aging (Albany NY). 2019. PMID: 31581133 Free PMC article.
Potassium channels as novel molecular targets in hepatocellular carcinoma (Review).
Chen X, Zhang L, He L, Zheng L, Tuo B. Chen X, et al. Oncol Rep. 2023 Oct;50(4):185. doi: 10.3892/or.2023.8622. Epub 2023 Sep 1. Oncol Rep. 2023. PMID: 37654193 Free PMC article. Review.
Dynactin 2 acts as an oncogene in hepatocellular carcinoma through promoting cell cycle progression.
Li W, Chen J, Xiong Z, Zhou H, Huang S, Ren J, Liu B, Zhou T, Hu K. Li W, et al. Liver Res. 2022 Aug 11;6(3):155-166. doi: 10.1016/j.livres.2022.07.002. eCollection 2022 Sep. Liver Res. 2022. PMID: 39958200 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal